Infants exposed to gamma-aminobutyric acid-based anesthetics, such as sevoflurane or propofol, before 2 months of age showed faster development of visual brain responses by 2 to 5 months, according to a July 28 study in the Proceedings of the National Academy of Sciences.
Researchers from Boston Children’s Hospital and Boston-based Northeastern University recorded brain activity using electroencephalogram while infants viewed visual stimuli. The study is the first to demonstrate in humans that GABA-based anesthetics may influence early brain development, a mechanism previously observed in animal models.
Earlier findings published in BJA Open showed no significant long-term cognitive or behavioral effects. A large, international, multicenter trial of remifentanil dexmedetomidine versus standard-dose sevoflurane anesthesia in children ages 2 years or younger, or TREX, tested anesthetic combinations that limit GABA exposure in newborns.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
